-1- Supplemental Materials Distinct roles for ROCK1 and ROCK2 in the regulation of cell detachment Jianjian Shi, Xiangbing Wu, Michelle Surma, Sasidhar Vemula, Lumin Zhang, Yu Yang, Reuben Kapur and Lei Wei* *To whom correspondence should be addressed. E-mail: lewei@iupui.edu (L.W.) -2- sFigure 1. A 5.8 kb B X Bg Ex 2 X Ex 3 Bg Ex 2 B X ROCK2 locus (WT allele: +) B Ex 3 B Ex 3 B Neo B Ex 2 B X Bg X Neo Targeting vector Targeted allele (flox) 4.5 kb B X X Bg Ex 3 B Knockout allele Neo Probe B C WT ROCK2+/- ROCK2 WT allele (5.8 kb) KO allele (4.5 kb) Tail DNA Xba I (X) digestion ROCK1 GAPDH Heart homogenate sFigure 1. Generation of ROCK2+/- mice. A. Schematic illustration of the strategy used for disruption of ROCK2 gene. A targeting vector was constructed containing loxP sites (arrows) flanking exon 2 of ROCK2 and Frt sites (diamonds) flanking the PGK-Neo cassette. Restriction enzymes sites are shown for BamH I (B), Bgl II (Bg), Xba I (X) and genomic probe. We first obtained germline transmission of the ROCK2flox allele, which contains the loxP-flanked exon 2 and neo cassette. The ROCK2 knockout allele was generated by crossing male ROCK2+/flox mice with female Tie2-Cre mice to generate female ROCK2+/flox/Tie2-Cre mice. Female Tie2-Cre mice express Cre in the female germ cells prior to the expression in endothelial lineage, allowing germline deletion from floxed allele. B. Southern blot analysis of genomic DNA obtained from mouse tail. C. Western blot analysis of ROCK1 and ROCK2 levels in the heart of WT and ROCK2 heterozygous knockout mice showing 50% reduction in ROCK2 expression observed in ROCK2+/- heart homogenate. An anti-GAPDH was used to confirm equal loading. -3- sFigure 2. A 500 WT 400 * * ROCK1-/- 300 * * 200 * * 100 0 Day 1 2 3 4 Attached cells (% of day 1) Attached cells (% of day 1) B 400 WT * * ROCK2-/- 300 * * 200 * * 100 0 Day 1 2 3 4 sFigure 2. ROCK1 or ROCK2 deletion in mouse embryonic fibroblasts (MEFs) does not affect cell proliferation. Proliferation assays of wild type (WT) versus ROCK1-/- cells (A) and WT versus ROCK2-/- cells (B) were performed at a density of 1 x 106/plate in 10%FBS DMEM supplemented with 10%FBS. Cells were counted every 24 h. Cell viability was estimated by using trypan bleu staining. Assays were performed in triplicate. Attached viable cell number was expressed as percentage of attached cells at day 1. Error bars represent standard deviation * P < 0.05 vs. control of the same genotype. # P < 0.05 vs. WT under the same condition. -4- sFigure 3. siRNA: Control ROCK1 ROCK1 ROCK2 GAPDH ROCK2 siRNA: Control ROCK1 ROCK1 ROCK2 GAPDH ROCK2 GAPDH ROCK1&2 DOX Phalloidin p-MLC2 Merge Phalloidin p-MLC2 Merge siROCK1 siROCK1&2 siROCK2 siROCK1 siROCK1&2 siROCK2 Control siRNA B siRNA: Control Control siRNA A sFigure 3. siRNA-mediated knockdown of ROCK1 or ROCK2 mimics the effects of ROCK1 or ROCK2 deletion. A. Representative image of Western blot of ROCK1 and ROCK2 performed with cell lysates from WT MEFs transfected with scrambled siRNA, ROCK1 siRNA and ROCK2 siRNA. GAPDH was used to confirm equal loading. B. Representative images of rhodamine-phalloidin staining for F-actin (red), p-MLC staining (green) and DAPI staining (blue) of siRNA transfected cells with or without 3 M doxorubicin treatment for 16 h. Actomyosin contractile rings are indicated with white arrows and folded periphery membranes with white arrowheads. Bar, 50 m. -5- sFigure 4. Attached cells A 0.88% Floating cells B 5.37% 0.31% 14.15% WT WT 23.29% 62.25% 0.23% 2.11% 0.13% 3.40% ROCK1-/- 96.81% 0.85% Annexin V-FITC 7-AAD 1.69% 7-AAD 92.06% ROCK1-/- 22.57% 73.90% Annexin V-FITC sFigure 4. Representative scatter plots of apoptosis quantified by FACS analysis after staining with Annexin V and 7-amino-actomyocin D (7-AAD) in attached (A) and floating (B) WT and ROCK1-/- cells collected after treatment for 16 h with 3 M doxorubicin. Viable cells are Annexin V−/7-AAD−. Annexin V+/7-AAD− cells are in early apoptosis, whereas Annexin V+/7-AAD+ cells are in late apoptosis, and have lost cell membrane integrity and taken up 7-AAD. Necrotic cells are Annexin V−/7-AAD+. -6- sFigure 5 50 40 30 20 10 0 CytoD 0.2 M DOX 1 M C *¶ * *# * - + - + WT + + - # * * + - + ROCK1-/- + + ¶ ROCK1-/(0.2 M CytoD) ROCK1-/- Attached cells (% of control) Floating cells (% of total cells) B WT (0.2 M CytoD) WT A 120 100 80 60 40 20 0 CytoD 0.2 M DOX 1 M * * - + - * *¶ + + + WT *# * - + - + # ¶ + + ROCK1-/- sFigure 5. Disruption of stress fibers by cytochalasin D facilitates doxorubicin-induced cell detachment. A. Representative images of rhodamine-phalloidin staining for F-actin of WT and ROCK1 deficient cells treated with 0.2 M cytochalasin D for 4 h. Bar, 50 m. B and C. Floating cells and attached cells were separately collected and counted after treatment with 1 M doxorubicin and/or 0.2 M cytochalasin D for 16 h. * P < 0.05 vs. control of the same genotype. # P < 0.05 vs. WT under the same treatment condition. ¶ P < 0.05 vs. the same genotype under doxorubicin only condition.